Misonix.jpg
Misonix Reports Fourth Quarter and Fiscal Year 2021 Financial Results
September 02, 2021 16:01 ET | MISONIX, Inc.
FARMINGDALE, N.Y., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix.jpg
Misonix Reports Fiscal 2021 Third Quarter Financial Results
May 06, 2021 16:01 ET | MISONIX, Inc.
FARMINGDALE, N.Y., May 06, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix.jpg
Misonix Receives Health Canada Approval for neXus
March 04, 2021 09:25 ET | MISONIX, Inc.
FARMINGDALE, N.Y., March 04, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
misonix.jpg
Misonix Reports Record Quarterly Revenue of $19.7 Million for Fiscal 2020 Second Quarter
February 05, 2020 16:05 ET | MISONIX, Inc.
FARMINGDALE, N.Y., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
misonix.jpg
Misonix Reports Preliminary Fiscal 2020 Second Quarter Revenue of Approximately $19.7 Million
January 13, 2020 08:05 ET | MISONIX, Inc.
FARMINGDALE, N.Y., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
1280px-Banco_Santander_Logotipo.svg.png
Credicorp Capital sells the majority of the Banco Santander Chile’s participation in Nexus
October 14, 2019 17:00 ET | Banco Santander Chile
SANTIAGO, Chile, Oct. 14, 2019 (GLOBE NEWSWIRE) -- We have the pleasure of communicating that the process of sale of a large portion of Banco Santander Chile’s portion in Nexus- an auxiliary...
misonix.jpg
Misonix Reports Fourth Quarter and Fiscal Year 2019 Results
August 14, 2019 16:05 ET | MISONIX, Inc.
FARMINGDALE, N.Y., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
misonix.jpg
Misonix Announces CE Mark Approval for Nexus
August 12, 2019 11:20 ET | MISONIX, Inc.
FARMINGDALE, N.Y., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
Sonatype’s Nexus User Conference to Bring 2,000 DevSecOps Leaders Together for Free, Live Streamed Event
June 10, 2019 10:16 ET | Sonatype
FULTON, MD, June 10, 2019 (GLOBE NEWSWIRE) -- Sonatype, the inventors of software supply chain automation, will host its second annual Nexus User Conference on June 12, 2019. The free, live, and...
misonix.jpg
Misonix Reports Fiscal 2019 Third Quarter Revenue of $9.6 Million
May 08, 2019 16:05 ET | MISONIX, Inc.
FARMINGDALE, N.Y., May 08, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...